Renal Therapeutics Market: Global Industry Analysis, Business Development, Size, Share, Trends, Future Growth, Forecast To 2026

Renal Therapeutics Market: Global Industry Analysis, Business Development, Size, Share, Trends, Future Growth, Forecast To 2026

The MarketWatch News Department was not involved in the creation of this content.

Sep 07, 2020 (The Expresswire) —
The global renal therapeutic market is projected to gain impetus from the rising number of geriatric population across the globe. According to a report by Fortune Business Insights, titled, “Renal Therapeutics Market Size, Share and Global Trend by Application (Chronic kidney disease, Diabetes, Kidney stone disease, Kidney failure, Others), by Drug Class (Angiotensin-II receptor blockers, ACE Inhibitors, Calcium channel blockers, Beta-blockers, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Geography Forecast till 2026,” the global renal therapeutics market is likely to grow at a fast pace due to the increasing number of kidney diseases among the populace.

Request a Sample Copy of the Research Report:https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/renal-therapeutics-market-100583

Leading Players operating in the Renal Therapeutics Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

  • Bristol-Myers Squibb Company,
  • Amgen Inc.,
  • Vifor Pharma Inc.,
  • Novartis AG,
  • Merck and Co., Inc.,
  • Johnson and Johnson Services, Inc.,
  • Pfizer Inc.,
  • Bayer AG,
  • AstraZeneca,

Janssen Pharmaceutica, Inc., Vifor Pharma Inc., and Other Key Players Are Focusing on Development of New Drugs

Janssen Pharmaceutica, Inc., a pharmaceutical company based in Belgium, announced the submission of a supplemental New Drug Application (sNDA) to the U.S. FDA in March 2019. The submission was for canagliflozin, the first diabetic drug used to treat chronic kidney diseases in type 2 diabetic patients. AstraZeneca, a multinational pharmaceutical headquartered in the U.K., announced in February 2019, that the Food and Drug Administration approved the company’s expanded label indication of dapagliflozin. It can be now used for the treatment of type 2 diabetes as well as moderate renal impairment. Previously, in June 2018, the Food and Drugs Administration approved the expansion of Mircera for the treatment of anemia that is associated with chronic kidney diseases. Mircera is a product of Vifor Pharma Inc., a prominent pharmaceutical company based in Switzerland.

Market Segmentation:

By Application

  • Chronic kidney disease
  • Diabetes
  • Kidney stone disease
  • Kidney failure
  • Others

By Drug Class

  • Angiotensin-II receptor blockers
  • ACE Inhibitors
  • Calcium channel blockers
  • Beta-blockers
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Geography

  • North America (USA and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico and Rest of Latin America)
  • Middle East and Africa (South Africa, GCC and Rest of Middle East and Africa)

Reasons to Purchase this Report:

  • Comprehensive analysis of the Renal Therapeutics Market growth drivers, obstacles, opportunities, and other related challenges.
  • Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and joint ventures.
  • Identifies market restraints and boosters.
  • Identifies all the possible segments present in the market to aid organizations in strategic business planning.

Have Any Query? Ask Our Experts:https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/renal-therapeutics-market-100583

KEY QUESTIONS ANSWERED:

  • What are the key technological and Renal Therapeutics Market trends shaping the market?
  • What are the key opportunities in the market?
  • What are the key companies operating in the market?
  • Which company accounted for the highest market share?
  • Why Choose Fortune Business Insights?
  • What is the market size and growth rate of the global and regional market by various segments?
  • What is the market size and growth rate of the market for selective countries?
  • Which region or sub-segment is expected to drive the market in the forecast period?
  • What Factors are estimated to drive and restrain the Renal Therapeutics Market growth?

More Trending Topics From Fortune Business Insights@

Anti-Fungal Drugs Market

Anti-Fungal Drugs Market

Anti-Fungal Drugs Market

Anti-Fungal Drugs Market

Anti-Fungal Drugs Market

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune – 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email:sales@fortunebusinessinsights.com

Linkedin|Twitter|BLogs

Press Release Distributed by The Express Wire

To view the original version on The Express Wire visit Renal Therapeutics Market: Global Industry Analysis, Business Development, Size, Share, Trends, Future Growth, Forecast To 2026

COMTEX_370842266/2598/2020-09-07T04:35:27

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

The MarketWatch News Department was not involved in the creation of this content.

Source Article